
### [MONDO:0017344](http://purl.obolibrary.org/obo/MONDO_0017344)
**Label:** Epstein-Barr virus-associated carcinoma

**Subclasses:** [MONDO:0017348](http://purl.obolibrary.org/obo/MONDO_0017348) (lymphoepithelial-like carcinoma), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0017784](http://purl.obolibrary.org/obo/MONDO_0017784) (Epstein-Barr virus-associated gastric carcinoma), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharynx carcinoma), 

**Corr. equiv. classes:** [OMIM:161550](http://purl.obolibrary.org/obo/OMIM_161550), [Orphanet:150](http://www.orpha.net/ORDO/Orphanet_150), [OMIM:607107](http://purl.obolibrary.org/obo/OMIM_607107), [OMIM:617075](http://purl.obolibrary.org/obo/OMIM_617075), [Orphanet:313920](http://www.orpha.net/ORDO/Orphanet_313920), [Orphanet:289682](http://www.orpha.net/ORDO/Orphanet_289682), 

**Class expressions from DL-Learner:**

- Thing 25.88%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 25.88%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 18.97%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 18.95%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 18.95%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 17.60%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.39%


